|
Guadarrama-Flores B, Matencio A, Navarro-Orcajada S, Martinez-Lede I, Conesa I, Vidal-Sanchez FJ, Garcia-Carmona F, Lopez-Nicolas JM. Development if healthy milk and yogurt products for reducing metabolic diseases using cyclodextrin and omega-3 fatty acids from fish oil. Food Funct. 2022 May 23;13(10):5528-5535. doi: 10.1039/d2fo00578f. PubMed PMID: 35522849.
AÑO: 2022; IF: 6.1
|
35522849
|
Navarro-Orcajada S, Conesa I, Matencio A, Rodriguez-Bonilla P, Garcia-Carmona F, Lopez-Nicolas JM. The use of cyclodextrins as solubility enhancers in the ORAC method may cause interference in the measurement of antioxidant activity. Talanta. 2022 Jun 1;243:123336. doi: 10.1016/j.talanta.2022.123336. Epub 2022 Feb 26. PubMed PMID: 35240366.
AÑO: 2022; IF: 6.1
|
|
Navarro-Orcajada S, Matencio A, Vicente-Herrero C, Garcia-Carmona F, Lopez-Nicolas JM. Study of the fluorescence and interaction between cyclodextrins and neochlorogenic acid, in comparison with chlorogenic acid. Sci Rep. 2021 Feb 8;11(1):3275. doi: 10.1038/s41598-021-82915-9. PubMed PMID: 33558562; PubMed Central PMCID: PMC7870928.
AÑO: 2021; IF: 4.996
|
|
Matencio A, Navarro-Orcajada S, Gonzalez-Ramon A, Garcia-Carmona F, Lopez-Nicolas JM. Recent advances in the treatment of Niemann pick disease type C: A mini-review. Int J Pharm. 2020 Jun 30;584:119440. doi: 10.1016/j.ijpharm.2020.119440. Epub 2020 May 16. PubMed PMID: 32428546.
AÑO: 2020; IF: 5.875
|
|
Matencio A, Caldera F, Cecone C, Lopez-Nicolas JM, Trotta F. Cyclic Oligosaccharides as Active Drugs, an Updated Review. Pharmaceuticals (Basel). 2020 Sep 29;13(10):281. doi: 10.3390/ph13100281. PubMed PMID: 33003610; PubMed Central PMCID: PMC7601923.
AÑO: 2020
|